Due to its expression in a significant number of osteosarcoma tumors and an abundant presence of immune cells, the PD-L1:PD-1 axis may be a promising target for immunotherapy in osteosarcoma, particularly given osteosarcoma known genetic complexity. The gene discussed is CD274; the disease is osteosarcoma.